Cargando…

The effect of reparixin on survival in patients at high risk for in-hospital mortality: a meta-analysis of randomized trials

INTRODUCTION: A great number of anti-inflammatory drugs have been suggested in the treatment of SARS-CoV-2 infection. Reparixin, a non-competitive allosteric inhibitor of the CXCL8 (IL-8) receptors C-X-C chemokine receptor type 1 (CXCR1) and C-X-C chemokine receptor type 2 (CXCR2), has already been...

Descripción completa

Detalles Bibliográficos
Autores principales:	Landoni, Giovanni, Zangrillo, Alberto, Piersanti, Gioia, Scquizzato, Tommaso, Piemonti, Lorenzo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9358031/ https://www.ncbi.nlm.nih.gov/pubmed/35958623 http://dx.doi.org/10.3389/fimmu.2022.932251

Ejemplares similares

A Multicenter Phase 2 Randomized Controlled Study on the Efficacy and Safety of Reparixin in the Treatment of Hospitalized Patients with COVID-19 Pneumonia
por: Landoni, Giovanni, et al.
Publicado: (2022)

Extracorporeal cardiopulmonary resuscitation for out‐of‐hospital cardiac arrest: A systematic review and meta‐analysis of randomized and propensity score‐matched studies
por: Scquizzato, Tommaso, et al.
Publicado: (2022)

Assessment of noise levels in the intensive care unit using Apple Watch
por: Scquizzato, Tommaso, et al.
Publicado: (2020)

Randomised trials of temperature management in cardiac arrest: Are we observing the Zeno’s paradox of the Tortoise and Achilles?
por: Scquizzato, Tommaso, et al.
Publicado: (2021)

Efficacy and Safety of Reparixin in Patients with Severe COVID-19 Pneumonia: A Phase 3, Randomized, Double-Blind Placebo-Controlled Study
por: Piemonti, Lorenzo, et al.
Publicado: (2023)

Enhancing citizens response to out-of-hospital cardiac arrest: A systematic review of mobile-phone systems to alert citizens as first responders
por: Scquizzato, Tommaso, et al.
Publicado: (2020)

Effects of COVID-19 pandemic on out-of-hospital cardiac arrests: A systematic review
por: Scquizzato, Tommaso, et al.
Publicado: (2020)

Propofol and survival: an updated meta-analysis of randomized clinical trials
por: Kotani, Yuki, et al.
Publicado: (2023)

COVID-19 seasonality in temperate countries
por: D'Amico, Filippo, et al.
Publicado: (2022)

Multiple anti-tumor effects of Reparixin on thyroid cancer
por: Liotti, Federica, et al.
Publicado: (2017)

The Effect of Statins on Mortality in Septic Patients: A Meta-Analysis of Randomized Controlled Trials
por: Pasin, Laura, et al.
Publicado: (2013)

The protective effects of reparixin against endothelial ischemia-reperfusion injury
por: Thitiwuthikiat, Piyanuch, et al.
Publicado: (2022)

Incidence, characteristics, and outcome of out-of-hospital cardiac arrest in Italy: A systematic review and meta-analysis
por: Scquizzato, Tommaso, et al.
Publicado: (2022)

Anticoagulation as secondary prevention of massive lung thromboses in hospitalized patients with COVID-19
por: Sofia, Rosaria, et al.
Publicado: (2022)

The Effect of Heparin Full-Dose Anticoagulation on Survival of Hospitalized, Non-critically Ill COVID-19 Patients: A Meta-analysis of High Quality Studies
por: Pilia, Eros, et al.
Publicado: (2023)

Intermittent furosemide administration in patients with or at risk for acute kidney injury: Meta-analysis of randomized trials
por: Bove, Tiziana, et al.
Publicado: (2018)

Efficacy and safety of IL-6 inhibitors in patients with COVID-19 pneumonia: a systematic review and meta-analysis of multicentre, randomized trials
por: Belletti, Alessandro, et al.
Publicado: (2021)

Preoperative intra-aortic balloon pump to reduce mortality in coronary artery bypass graft: a meta-analysis of randomized controlled trials
por: Zangrillo, Alberto, et al.
Publicado: (2015)

Dexmedetomidine as a Sedative Agent in Critically Ill Patients: A Meta-Analysis of Randomized Controlled Trials
por: Pasin, Laura, et al.
Publicado: (2013)

Correction: Dexmedetomidine as a Sedative Agent in Critically Ill Patients: A Meta-Analysis of Randomized Controlled Trials
por: Pasin, Laura, et al.
Publicado: (2014)

Anakinra for patients with COVID-19 – Authors' reply
por: Cavalli, Giulio, et al.
Publicado: (2020)

Letter to the Editor Regarding a Multicentric Phase 2 Randomized Controlled Study on the Efficacy and Safety of Reparixin in the Treatment of Hospitalized Patients with COVID-19 Pneumonia
por: Ito, Shun, et al.
Publicado: (2022)

A window-of-opportunity trial of the CXCR1/2 inhibitor reparixin in operable HER-2-negative breast cancer
por: Goldstein, Lori J., et al.
Publicado: (2020)

Additive Effect on Survival of Anaesthetic Cardiac Protection and Remote Ischemic Preconditioning in Cardiac Surgery: A Bayesian Network Meta-Analysis of Randomized Trials
por: Zangrillo, Alberto, et al.
Publicado: (2015)

Anakinra for patients with COVID-19: a meta-analysis of non-randomized cohort studies.
por: Pasin, Laura, et al.
Publicado: (2021)

Response to “Letter to the Editor Regarding a Multicenter Phase 2 Randomized Controlled Study on the Efficacy and Safety of Reparixin in the Treatment of Hospitalized Patients with COVID-19 Pneumonia”
por: Mantelli, Flavio
Publicado: (2022)

Correction to: A window-of-opportunity trial of the CXCR1/2 inhibitor reparixin in operable HER-2-negative breast cancer
por: Goldstein, Lori J., et al.
Publicado: (2020)

Corticosteroids for Patients With Coronavirus Disease 2019 (COVID-19) With Different Disease Severity: A Meta-Analysis of Randomized Clinical Trials
por: Pasin, Laura, et al.
Publicado: (2021)

Non-Adrenergic Vasopressors in Patients with or at Risk for Vasodilatory Shock. A Systematic Review and Meta-Analysis of Randomized Trials
por: Belletti, Alessandro, et al.
Publicado: (2015)

Preventing mortality in cardiac surgery with anesthetic drugs and techniques. There is need for a consensus conference
por: Landoni, G, et al.
Publicado: (2010)

The CXCR1/CXCR2 Inhibitor Reparixin Alters the Development of Myelofibrosis in the Gata1 (low) Mice
por: Verachi, Paola, et al.
Publicado: (2022)

Comment to: “Propofol and survival: an updated meta-analysis of randomized clinical trials”: authors’ reply
por: Kotani, Yuki, et al.
Publicado: (2023)

Protecting High-Risk Cardiac Patients During the COVID-19 Outbreak
por: Pisano, Antonio, et al.
Publicado: (2020)

Minimise nosocomial spread of 2019-nCoV when treating acute respiratory failure
por: Cabrini, Luca, et al.
Publicado: (2020)

Pneumothorax and barotrauma in invasively ventilated patients with COVID-19
por: Belletti, Alessandro, et al.
Publicado: (2021)

Respiratory Impairment Predicts Response to IL-1 and IL-6 Blockade in COVID-19 Patients With Severe Pneumonia and Hyper-Inflammation
por: Della-Torre, Emanuel, et al.
Publicado: (2021)

Blockade of CXCR1/2 chemokine receptors protects against brain damage in ischemic stroke in mice: Ischemia and Reparixin
por: da Cunha Sousa, Larissa Fonseca, et al.
Publicado: (2013)

Cardiothoracic Surgery at the Time of the Coronavirus Disease–2019 Pandemic: Lessons From the East (and From a Previous Epidemic) for Western Battlefields
por: Pisano, Antonio, et al.
Publicado: (2020)

MicroCLOTS pathophysiology in coronavirus disease 2019
por: Renzi, Samuele, et al.
Publicado: (2023)

The attractiveness of network meta-analysis: a comprehensive systematic and narrative review
por: Greco, Teresa, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_59iq98phhukrrtdg57ecvp7oal